Infliximab-Abda 100 Milligram Intravenous Solution Priced at $237.90 at Aurora Sheboygan
Infliximab-Abda is a biosimilar intravenous medication used to manage autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis by suppressing inflammation and modulating the immune system’s activity. At Aurora Sheboygan Medical Center, the cost for each 100-milligram IV dose is $237.90, which typically includes the drug itself and administration via infusion in a clinical setting. Patients should be aware that additional charges (such as facility or infusion fees, pre-infusion assessments, and labs) may apply. It is advisable to request an itemized cost estimate before treatment and clarify with your insurer about coverage and out-of-pocket responsibilities.
Cost Breakdown
- Infliximab-Abda (100 mg dose): $237.90 per vial/dose
- Infusion Administration Fee: May be billed separately (verify with provider)
- Facility or Nursing Charges: Possible additional fees for use of infusion center and nursing care
- Pre-infusion Laboratory Tests: Monitoring labs may be required prior to each infusion (billed separately)
Associated Costs
- Initial and follow-up clinic visits with your healthcare provider
- Laboratory tests for safety monitoring (liver function, blood counts, etc.)
- Other medications (e.g., pre-medications or adjunct therapies)
- Potential emergency care for infusion reactions (rare)
Insurance & Payment Advice
- Contact your insurance provider to confirm coverage for Infliximab-Abda and infusion services (CPT/revenue codes may be required).
- Ask about your plan’s deductible, co-insurance, and co-pay amounts for specialty infusions.
- Check if prior authorization is required for this medication/treatment.
- Inquire about financial assistance or manufacturer co-pay programs if cost is a concern.
Frequently Asked Questions
-
What is Infliximab-Abda used for?
Infliximab-Abda treats autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis by targeting inflammation. -
How is Infliximab-Abda administered?
It is given as an intravenous (IV) infusion in a clinical setting under medical supervision. -
How often will I need infusions?
Infusion frequency varies by diagnosis and response to therapy, but typically starts with more frequent doses before moving to maintenance every 4 to 8 weeks. -
What does the listed price include?
The $237.90 fee covers each 100-milligram vial of Infliximab-Abda; additional costs may apply for infusion services, facility use, and monitoring. -
Are there other fees besides the drug cost?
Yes, expect possible charges for infusion administration, facility fees, lab work, and provider visits. -
Does insurance cover Infliximab-Abda infusions?
Coverage varies by plan; contact your insurer to confirm benefits, required authorizations, and out-of-pocket responsibilities. -
Can I get a cost estimate before treatment?
Yes, you should request an itemized estimate from your provider or infusion center before starting therapy. -
Are there side effects or risks with Infliximab-Abda?
Potential side effects include infusion reactions, increased infection risk, and allergic responses. Your provider will discuss these and monitor you closely during and after infusions. -
Is financial assistance available for this medication?
Many manufacturers and specialty pharmacies offer co-pay assistance or patient support programs. Ask your provider or pharmacy for details. -
What should I do to prepare for my infusion?
Follow your provider’s instructions, which may include lab work, fasting, or bringing a list of medications. Bring entertainment and snacks, as infusions may take several hours.
Aurora Medical Center Sheboygan County offers a specialized medical service involving the administration of Infliximab-Abda, a 100-milligram intravenous solution priced at $237.90. This medication is typically used to treat autoimmune conditions such as rheumatoid arthritis, Crohn’s disease, and ulcerative colitis by reducing inflammation and altering the immune system’s response. The pricing at Aurora Sheboygan reflects the cost for each 100-milligram dose administered intravenously, providing patients with access to this important treatment option in managing chronic inflammatory conditions.
What is Infliximab-Abda? – Infliximab-Abda is a biosimilar medication used to treat various autoimmune diseases by targeting and neutralizing a specific protein in the body that causes inflammation.
How is Infliximab-Abda administered? – It is administered intravenously, meaning it is delivered directly into the bloodstream through an IV infusion, typically in a clinical setting.
What conditions does Infliximab-Abda treat? – This medication is used to manage conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis, ankylosing spondylitis, and psoriatic arthritis.
How often do patients need Infliximab-Abda infusions? – The frequency of infusions varies based on the condition being treated and the patient’s response, but it often starts with more frequent doses that taper to maintenance infusions every 6 to 8 weeks.
Are there any side effects associated with Infliximab-Abda? – Common side effects can include infections, infusion-related reactions, headaches, and abdominal pain, though serious side effects are rare and should be discussed with a healthcare provider.
Is Infliximab-Abda covered by insurance? – Coverage varies by insurance plan, so patients should check with their provider to understand their specific benefits and any potential out-of-pocket costs.
What should patients do if they miss a dose? – Patients should contact their healthcare provider as soon as possible to reschedule the missed infusion and discuss any potential impacts on their treatment plan.
Can Infliximab-Abda be used in children? – It is approved for use in certain pediatric conditions, but the decision to use it should be made by a healthcare provider based on the child’s specific medical needs.
What precautions should be taken before starting Infliximab-Abda? – Patients should inform their doctor of any infections, recent vaccinations, or other medical conditions, as well as any other medications they are taking, to ensure safe use of Infliximab-Abda.